Cell Therapy Potency Assay Summit

Jul 25 - Jul 27 2022

Strategies for Developing a Potency Assay for a Clonal Neoantigen-Reactive Cell Therapy Product

  • Carolyn Edwards Director, Research Programs, Achilles Therapeutics


• Showcasing options for measuring potency effectively
• Discussing data generation in Phase I trials
• Transition from early stage to late-stage development for potency assays
• Supporting characterization and development by designing phase appropriate potency assay

Print Page
RSS Feeds
Email Alerts
Contact IR